+9.9% · 90d
$59.72
+0.23 (+0.39%)
After-Hours $58.97(-0.75)
News
(1)April 2026
Vaxcyte Shareholders Vote on Board, Auditor, and Executive Pay
PCVXVaxcyte, Inc.
# 🧾 What This Document Is This is a **DEF 14A**, also called a **Proxy Statement**. It’s a formal notice sent to shareholders before an annual meeting. Its job is to explain what will be voted on and provide the information needed to make informed decisions. 👉 **In simple terms:** If you own stoc
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%